A Phase III, multicenter, randomized, double-blind, placebo controlled, parallel group study to assess the efficacy and safety of KRP-116D in Japanese patients with interstitial cystisis.
Status: Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 28 Nov 2018
Price : $35 *
At a glance
- Drugs Dimethyl sulfoxide (Primary)
- Indications Interstitial cystitis
- Focus Therapeutic Use
- Sponsors Kyorin Pharmaceutical
- 11 May 2018 Status changed from recruiting to active, no longer recruiting.
- 01 Aug 2017 Status changed from not yet recruiting to recruiting.
- 19 May 2017 New trial record